한글목차

세계의 폴리머 바이오소재 시장은 2025년에는 670억 3,000만 달러로 추정되며, 2032년에는 1,687억 6,000만 달러에 달할 것으로 예측되며, 2025-2032년의 CAGR은 14.1%로 추이할 것으로 예측됩니다.

도표. 세계의 폴리머 바이오소재 시장 점유율 지역별(%) 2025년

폴리머 바이오소재는 생체적합성 고분자로 의료용 및 의료기기에 사용되는 생체적합성 고분자입니다. 생분해성과 생체적합성 특성으로 인해 조직공학 및 재생의료 분야에서 중요한 역할을 하고 있습니다. 폴리머 바이오소재에는 콜라겐, 엘라스틴과 같은 천연 고분자와 폴리글리콜산(PGA), 폴리유산(PLA), 폴리카프로락톤(PCL)과 같은 합성 고분자가 있습니다. 이러한 폴리머는 물리화학적 특성과 분해 거동을 조절할 수 있으므로 약물전달체, 의료용 임플란트, 조직 재생을 위한 스캐폴더로 매력적인 후보입니다. 세계 폴리머 바이오소재 시장은 심혈관, 정형외과, 치과, 상처 치유 분야에서 폴리머 바이오소재의 사용이 증가함에 따라 괄목할 만한 성장세를 보이고 있습니다.

시장 역학:

세계의 폴리머 바이오소재 시장은 주로 만성질환의 유병률 증가, 노인 인구 증가, 의료용 임플란트 및 조직공학 시술 증가에 의해 주도되고 있습니다. 유엔에 따르면 65세 이상 인구는 2020년 7억 3천만 명에서 2050년 15억 명으로 증가할 것으로 예측됩니다. 고령화 인구 증가는 임플란트, 조직 스캐폴딩 및 기타 의료용으로 사용되는 폴리머 바이오소재에 대한 수요를 증가시킬 것으로 예측됩니다. 또한 분해 특성을 조절할 수 있는 새로운 생체흡수성 폴리머의 개발, 가공 기술의 다양성, 재생 의학 연구 증가도 시장 성장을 가속하고 있습니다. 그러나 까다로운 규제 당국의 승인 과정과 높은 연구개발(R&D) 관련 비용은 시장 확대에 걸림돌이 될 수 있습니다. 그럼에도 불구하고 신흥 국가의 헬스케어 투자 확대와 의료 기술 발전은 예측 기간 중 새로운 기회를 창출할 것으로 예측됩니다.

본 조사의 주요 특징

• 세계의 폴리머 바이오소재 시장에 대해 조사 분석하고, 2024년을 기준 연도로 하여 예측기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 폴리머 바이오소재 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계의 폴리머 바이오소재 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 폴리머 바이오소재 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 주요 하이라이트
• 규제 시나리오
• 최근 동향
• PEST 분석
• PORTER의 산업 분석
• 합병, 인수 및 제휴

제4장 세계의 폴리머 바이오소재 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 폴리머 바이오소재 시장, 제품별, 2020-2032년

• 폴리유산(PLA)
• 폴리글리콜산(PGA)
• 폴리우레탄
• 폴리테트라플루오로에틸렌(PTFE) 및 연신 폴리테트라플루오로에틸렌(ePTFE)
• PEEK(Polyaryletheretherketone)
• PDO(Polydioxanone)
• 기타

제6장 세계의 폴리머 바이오소재 시장, 용도별, 2020-2032년

• 심혈관계
• 생체흡수성 스텐트
• 혈관이식
• 센서
• 가이드와이어
• 이식형 심장 제세동기
• 페이스메이커
• 기타
• 치과
• 조직 재생 재료
• 치과 임플란트
• 골이식 및 뼈대체물
• 치과용 막
• 치과 봉합사
• 기타
• 정형외과
• 관절 치환 폴리머 생체 재료
• 조직 고정 제품
• 오소바이오로직스
• 관절내 보충 요법
• 척추 생체 재료
• 기타
• 성형 외과
• 얼굴 주름 치료
• 연부조직 필러
• 두개 안면 외과
• 바이오엔지니어링 스킨
• 말초신경 수복
• 무세포 진피 매트릭스
• 기타
• 신경학
• 신경줄기세포 인캡슐레이션
• 입환 시스템
• 중추신경계 수복을 위한 하이드로겔 스캐폴드
• 피질 신경보철
• 기타

제7장 세계의 폴리머 바이오소재 시장, 지역별, 2020-2032년

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제8장 경쟁 구도

• 기업 개요
  • Stryker
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc(Invibio Ltd.)
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation

제9장 섹션

• 참고 문헌
• 조사 방법
• 출판사 소개

영문목차

Global Polymeric Biomaterials Market is estimated to be valued at USD 67.03 Bn in 2025 and is expected to reach USD 168.76 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.1% from 2025 to 2032.

Figure. Global Polymeric Biomaterials Market Share (%), By Region 2025

Polymeric biomaterials are polymers that are biocompatible and are used in medical applications and devices. They plays an important role in tissue engineering and regenerative medicine applications due to their biodegradability and biocompatibility properties. Polymeric biomaterials can be natural polymers such as collagen, elastin or synthetic polymers like polyglycolic acid(PGA), polylactic acid (PLA) or polycaprolactone (PCL). These polymers are attractive candidates for drug delivery vehicles, medical implants, and scaffolds for tissue regeneration due to their tunable physicochemical properties and degradation behavior. Global polymeric biomaterials market is growing at a significant rate due to the increasing use of polymeric biomaterials in cardiovascular, orthopedic, dental and wound healing applications.

Market Dynamics:

Global polymeric biomaterials market is primarily driven by the rising prevalence of chronic diseases, growing geriatric population, increasing medical implants and tissue engineering procedures. According to the United Nations, the number of people aged 65 years and above is projected to grow from 703 Mn in 2020 to 1.5 billion by 2050. The increase in ageing population is expected to boost the demand for polymeric biomaterials used in implants, tissue scaffolds and other medical applications. Moreover, development of novel bioabsorbable polymers with tunable degradation properties, versatility in processing techniques and increasing research in regenerative medicine also helps to fuel the market growth. However, stringent regulatory approval process and high costs associated with research and development (R&D) could hamper the market expansion. Nevertheless, growing healthcare investments in emerging nations and ongoing advancements in medical technology are projected to unlock new opportunities over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global polymeric biomaterials market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global polymeric biomaterials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Stryker, BASF SE, Evonik Industries AG, DSM, Bezwada Biomedical, LLC, Corbion, Victrex plc (Invibio Ltd.), International Polymer Engineering, Covalon Technologies Ltd., Medtronic, Abbott, Elixir Medical, REVA Medical, LLC, Meril Life Sciences Pvt. Ltd., and MicroPort Scientific Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global polymeric biomaterials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global polymeric biomaterials market

Detailed Segmentation:

• Global Polymeric Biomaterials Market, By Product
  • Polylactic Acid (PLA)
  • Polyglycolic Acid (PGA)
  • Polyurethanes
  • Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
  • Polyaryletheretherketone (PEEK)
  • Polydioxanone (PDO)
  • Others
• Global Polymeric Biomaterials Market, By Application
  • Cardiovascular
  • Bioresorbable Stents
  • Vascular Grafts
  • Sensors
  • Guidewires
  • Implantable Cardiac Defibrillators
  • Pacemakers
  • Others
  • Dental
  • Tissue Regeneration Materials
  • Dental Implants
  • Bone Grafts & Substitutes
  • Dental Membranes
  • Dental Sutures
  • Others
  • Orthopedic
  • Joint Replacement Polymeric Biomaterials
  • Tissue Fixation Products
  • Suture Anchors
  • Others
  • Orthobiologics
  • Viscosupplementation
  • Spine Biomaterials
  • Others
  • Plastic Surgery
  • Facial Wrinkle Treatment
  • Soft Tissue Fillers
  • Craniofacial Surgery
  • Sutures
  • Others
  • Bioengineered Skins
  • Peripheral Nerve Repair
  • Acellular Dermal Matrices
  • Others
  • Neurology
  • Neural Stem Cell Encapsulation
  • Shunting Systems
  • Hydrogel Scaffold For CNS Repair
  • Cortical Neural Prosthetics
  • Others
  • Others
• Global Polymeric Biomaterials Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Stryker
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc (Invibio Ltd.)
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Polymeric Biomaterials Market, By Product
  • Global Polymeric Biomaterials Market, By Application
  • Global Polymeric Biomaterials Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing orthopedic and dental applications
  • Stringent regulatory environment
  • Emerging markets in Asia Pacific and Latin America
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Polymeric Biomaterials Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Polymeric Biomaterials Market, By Product, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Polylactic Acid (PLA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polyglycolic Acid (PGA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polyurethanes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polyaryletheretherketone (PEEK)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polydioxanone (PDO)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Polymeric Biomaterials Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Bioresorbable Stents
• Vascular Grafts
• Sensors
• Guidewires
• Implantable Cardiac Defibrillators
• Pacemakers
• Others
• Dental
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tissue Regeneration Materials
• Dental Implants
• Bone Grafts & Substitutes
• Dental Membranes
• Dental Sutures
• Others
• Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Joint Replacement Polymeric Biomaterials
• Tissue Fixation Products
  • Suture Anchors
  • Others
• Orthobiologics
• Viscosupplementation
• Spine Biomaterials
• Others
• Plastic Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Facial Wrinkle Treatment
• Soft Tissue Fillers
• Craniofacial Surgery
  • Sutures
  • Others
• Bioengineered Skins
• Peripheral Nerve Repair
• Acellular Dermal Matrices
• Others
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neural Stem Cell Encapsulation
• Shunting Systems
• Hydrogel Scaffold For CNS Repair
• Cortical Neural Prosthetics
• Others
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Polymeric Biomaterials Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profile
  • Stryker
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc (Invibio Ltd.)
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
• Analyst Views

9. Section

• References
• Research Methodology
• About us